Description
Product Characteristics: 4-galactosyltransferase 5 antibody, 4-GalT II antibody, 4-GalTase 5 antibody, B4Gal T5 antibody, b4Gal-T5 antibody, B4galt5 antibody, B4GT5_HUMAN antibody, Beta 1 4 galactosyltransferase 5 antibody, Beta 1 4 galactosyltransferase V antibody, Beta 1 4 GalT II antibody, Beta 1 4 GalT IV antibody, Beta 1 4 GalTase 5 antibody, Beta-1 antibody, Beta-1,4-galactosyltransferase 5 antibody, Beta-1,4-GalT II antibody, Beta-1,4-GalTase 5 antibody, Beta4 GALT IV antibody, Beta4Gal T5 antibody, Beta4Gal-T5 antibody, Beta4GalT V antibody, gt V antibody, gtV antibody, MGC138470 antibody, UDP Gal:beta GlcNAc beta 1 4 galactosyltransferase 5 antibody, UDP Gal:betaGlcNAc beta 1 4 galactosyltransferase 5 antibody, UDP Gal:betaGlcNAc beta 1 4 galactosyltransferase polypeptide 5 antibody, UDP galactose:beta N acetylglucosamine beta 1 4 galactosyltransferase 5 antibody, UDP-Gal:beta-GlcNAc beta-1 antibody, UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5 antibody, UDP-galactose:beta-N-acetylglucosamine beta-1 antibody, UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5 antibody
Target Information: This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose\, all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. The function of the enzyme encoded by this gene is not clear. This gene was previously designated as B4GALT4 but was renamed to B4GALT5. In the literature it is also referred to as beta4GalT2. [provided by RefSeq, Jul 2008]